Comparing Ramsay Health Care (OTCMKTS:RMYHY) and Henry Schein (NASDAQ:HSIC)

Henry Schein (NASDAQ:HSIC) and Ramsay Health Care (OTCMKTS:RMYHY) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

Profitability

This table compares Henry Schein and Ramsay Health Care’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Henry Schein	2.96%	15.97%	5.56%
Ramsay Health Care	N/A	N/A	N/A

Institutional & Insider Ownership

96.6% of Henry Schein shares are held by institutional investors. 0.9% of Henry Schein shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

Henry Schein has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Ramsay Health Care has a beta of -0.04, suggesting that its share price is 104% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Henry Schein and Ramsay Health Care, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1	5	9	0	2.53
Ramsay Health Care	1	1	0	1	2.33

Henry Schein presently has a consensus price target of $92.93, indicating a potential upside of 3.48%. Given Henry Schein’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Henry Schein is more favorable than Ramsay Health Care.

Valuation & Earnings

This table compares Henry Schein and Ramsay Health Care”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18 billion	0.76	$398.00 million	$3.43	26.18
Ramsay Health Care	N/A	N/A	N/A	N/A	N/A

Henry Schein has higher revenue and earnings than Ramsay Health Care.

Summary

Henry Schein beats Ramsay Health Care on 10 of the 11 factors compared between the two stocks.

About Henry Schein

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

About Ramsay Health Care

Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.